Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus
DOI:
https://doi.org/10.37506/ijfmt.v16i4.18570Keywords:
: COVID-19, efficacy, lopinavir, ritonavir, side effectsAbstract
Background: Lopinavir/ritonavir is an antiviral studied for its effectiveness in healing severe COVID-19 infection;
however, it remains debated. This study determined the efficacy and evaluated the side effects of lopinavir/
ritonavir on severe COVID-19 patients with comorbid hypertension and diabetes mellitus.
Methods: Retrospective data collection was conducted from June to December 2020. The data were then analyzed
descriptively. Severe COVID-19 patients with hypertension and diabetes mellitus who received lopinavir/
ritonavir were grouped into groups A, B, C, D and observed based on other pharmaceutical therapies (antibiotics,
corticosteroids, anticoagulants, multivitamins and supplements, comorbid therapy, and symptomatic therapy)
obtained. The efficacy of lopinavir/ritonavir was identifiable through RT-PCR, oxygenation saturation, and chest
X-ray. The side effects of lopinavir/ritonavir were also be evaluated.
Results: Only 21 total sample met the inclusion criteria. The oral administration of lopinavir/ritonavir
(2 x 400/100 mg) was effective in groups A, B, C, and D whose negative RT-PCR results were respectively 10%,
48%, 5%, and 14%; normal oxygen saturation with the administration of oxygen therapy was 10%, 33%, 5%, and
5%, respectively; and chest X-ray improvement was 10%, 29%, 5%, and 14%, respectively. Lopinavir/ritonavir
could increase SGOT (46%), SGPT (27%), as well as a QT interval prolongation (5%).
Conclusion: The administration of lopinavir/ritonavir is effective to rule out negative RTPCR results, improve
chest X-ray imaging and oxygen saturation. Monitoring side effects merits more attention to avoid those potential
side effects of the therapies
Downloads
Published
Issue
Section
License
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions